Masataka Ohba

566 total citations
25 papers, 517 citations indexed

About

Masataka Ohba is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Masataka Ohba has authored 25 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 11 papers in Physiology. Recurrent topics in Masataka Ohba's work include Neuropeptides and Animal Physiology (14 papers), Pain Mechanisms and Treatments (11 papers) and Receptor Mechanisms and Signaling (8 papers). Masataka Ohba is often cited by papers focused on Neuropeptides and Animal Physiology (14 papers), Pain Mechanisms and Treatments (11 papers) and Receptor Mechanisms and Signaling (8 papers). Masataka Ohba collaborates with scholars based in Japan, Belgium and Sweden. Masataka Ohba's co-authors include Kensuke Kisara, Tsukasa Sakurada, Hiromichi Kumagai, Shinobu Sakurada, Koichi Tan‐No, Yukio Ueno, Toshihide Yamada, Hikoichi Sakai, Naoto Yonezawa and Eisuke Nishida and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and Pain.

In The Last Decade

Masataka Ohba

25 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masataka Ohba Japan 13 278 256 194 74 66 25 517
W. M. Potts United States 12 486 1.7× 232 0.9× 71 0.4× 41 0.6× 58 0.9× 21 769
Bruce R. Lester United States 15 293 1.1× 119 0.5× 62 0.3× 120 1.6× 125 1.9× 28 603
Rainer Harhammer Germany 14 595 2.1× 187 0.7× 71 0.4× 73 1.0× 117 1.8× 19 751
Ronald C. Haaseth United States 14 485 1.7× 459 1.8× 190 1.0× 46 0.6× 21 0.3× 20 686
Alka Shrikhande United States 12 529 1.9× 131 0.5× 78 0.4× 89 1.2× 48 0.7× 30 821
Cynthia B. Zeller United States 7 369 1.3× 131 0.5× 96 0.5× 13 0.2× 106 1.6× 17 587
Kaori Ihida Japan 8 329 1.2× 173 0.7× 86 0.4× 41 0.6× 176 2.7× 17 571
Helen Waller‐Evans United Kingdom 10 257 0.9× 112 0.4× 87 0.4× 48 0.6× 77 1.2× 17 516
Miki Hara‐Yokoyama Japan 17 587 2.1× 78 0.3× 235 1.2× 23 0.3× 243 3.7× 51 958
P.E.R. Tatham United Kingdom 14 417 1.5× 133 0.5× 72 0.4× 44 0.6× 185 2.8× 19 765

Countries citing papers authored by Masataka Ohba

Since Specialization
Citations

This map shows the geographic impact of Masataka Ohba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Ohba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Ohba more than expected).

Fields of papers citing papers by Masataka Ohba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masataka Ohba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Ohba. The network helps show where Masataka Ohba may publish in the future.

Co-authorship network of co-authors of Masataka Ohba

This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Ohba. A scholar is included among the top collaborators of Masataka Ohba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Ohba. Masataka Ohba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakurada, Tsukasa, Makoto Inoue, Chikai Sakurada, et al.. (1999). Opioid activity of sendide, a tachykinin NK1 receptor antagonist. European Journal of Pharmacology. 369(3). 261–266. 12 indexed citations
2.
Nishino, Norikazu, et al.. (1996). Tandem Enzymatic Resolution Yielding L-.ALPHA.-AminoaLkanedioic Acid .OMEGA.-Esters.. Chemical and Pharmaceutical Bulletin. 44(1). 212–214. 7 indexed citations
3.
Matsumura, Yasushi, et al.. (1995). Structure/Activity Relationship of Chimeric Calcitonins. 1995. 313–316. 1 indexed citations
4.
Sakurada, Tsukasa, et al.. (1995). The neurokinin-1 receptor antagonist, sendide, exhibits antinociceptive activity in the formalin test. Pain. 60(2). 175–180. 34 indexed citations
5.
Sakurada, Tsukasa, et al.. (1994). Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice. European Journal of Pharmacology. 261(1-2). 85–90. 20 indexed citations
6.
Sakurada, Tomoya, et al.. (1994). Pharmacological characterisation of NK1 receptor antagonist, [D-Trp7]sendide, on behaviour elicited by substance P in the mouse. Naunyn-Schmiedeberg s Archives of Pharmacology. 350(4). 387–92. 6 indexed citations
7.
Sakurada, Tsukasa, et al.. (1994). Differential antinociceptive effects of sendide, a NK1-receptor antagonist, and morphine in the capsaicin test. Brain Research. 649(1-2). 319–322. 18 indexed citations
8.
Tan‐No, Koichi, et al.. (1993). A selective and extremely potent antagonist of the neurokinin-1 receptor. Regulatory Peptides. 46(1-2). 326–328. 4 indexed citations
9.
Sakurada, Tsukasa, et al.. (1993). Antinociceptive effects in the formalin and capsaicin tests after intrathecal administration of substance P analogues in mice. European Journal of Pharmacology. 242(1). 47–52. 23 indexed citations
10.
Sakurada, Tsukasa, Koichi Tan‐No, Shinobu Sakurada, et al.. (1992). A selective and extremely potent antagonist of the neurokinin-1 receptor. Brain Research. 593(2). 319–322. 30 indexed citations
11.
Mohri, Hiroshi, Yoshimi Hashimoto, Masataka Ohba, Hiromichi Kumagai, & Takao Ohkubo. (1991). Novel effect of cyclicization of the Arg‐Gly‐Asp‐containing peptide on vitronectin binding to platelets. American Journal of Hematology. 37(1). 14–19. 16 indexed citations
12.
Kumagai, Hiromichi, et al.. (1991). Effect of cyclic RGD peptide on cell adhesion and tumor metastasis. Biochemical and Biophysical Research Communications. 177(1). 74–82. 117 indexed citations
13.
Sakurada, Tsukasa, Takuya Yamada, Koichi Tan‐No, et al.. (1991). Differential effects of substance P analogs on neurokinin 1 receptor agonists in the mouse spinal cord.. Journal of Pharmacology and Experimental Therapeutics. 259(1). 205–210. 57 indexed citations
14.
Sakurada, Tsukasa, Koichi Tan‐No, Toshihide Yamada, et al.. (1990). N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice. Life Sciences. 47(20). PL109–PL113. 22 indexed citations
15.
Yonezawa, Naoto, et al.. (1989). An actin‐interacting heptapeptide in the cofilin sequence. European Journal of Biochemistry. 183(1). 235–238. 57 indexed citations
16.
Sakurada, Tsukasa, et al.. (1989). Substance P analogues containing D-histidine antagonize the behavioural effects of intrathecally co-administered substance P in mice. European Journal of Pharmacology. 174(2-3). 153–160. 45 indexed citations
17.
Sakurada, Tsukasa, Hiroyuki Kuwahara, Shinobu Sakurada, et al.. (1987). Behavioural assessment as substance P antagonists in mice. Neuropeptides. 9(3). 197–206. 19 indexed citations
18.
Hayashi, Hiroshi, Satoshi Minoshima, & Masataka Ohba. (1982). Autonomous Control of the Level of Methylation of Methyl-Accepting Chemotaxis Protein1. The Journal of Biochemistry. 92(2). 391–397. 1 indexed citations
19.
Minoshima, Satoshi, Masataka Ohba, & Hiroshi Hayashi. (1981). An In Vitro Study of the Methylation of Methyl-Accepting Chemotaxis Protein of Escherichia coli. Construction of the System and Effect of Mutant Proteins on the System. The Journal of Biochemistry. 89(2). 411–420. 3 indexed citations
20.
Ohba, Masataka, et al.. (1979). In Vivo Methylation of Elongation Factor Tu of Escherichia coli1. The Journal of Biochemistry. 86(5). 1233–1238. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. M. Potts Breakdown of academic impact, for papers by Bruce R. Lester Breakdown of academic impact, for papers by Rainer Harhammer Breakdown of academic impact, for papers by Ronald C. Haaseth Breakdown of academic impact, for papers by Alka Shrikhande Breakdown of academic impact, for papers by Cynthia B. Zeller Breakdown of academic impact, for papers by Kaori Ihida Breakdown of academic impact, for papers by Helen Waller‐Evans Breakdown of academic impact, for papers by Miki Hara‐Yokoyama Breakdown of academic impact, for papers by P.E.R. Tatham
Rankless by CCL
2026